Ge Shen

622 total citations
32 papers, 356 citations indexed

About

Ge Shen is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Ge Shen has authored 32 papers receiving a total of 356 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Epidemiology, 23 papers in Hepatology and 5 papers in Infectious Diseases. Recurrent topics in Ge Shen's work include Hepatitis B Virus Studies (23 papers), Hepatitis C virus research (21 papers) and Liver Disease Diagnosis and Treatment (15 papers). Ge Shen is often cited by papers focused on Hepatitis B Virus Studies (23 papers), Hepatitis C virus research (21 papers) and Liver Disease Diagnosis and Treatment (15 papers). Ge Shen collaborates with scholars based in China and United States. Ge Shen's co-authors include Yao Lu, Minghui Li, Lu Zhang, Min Chang, Leiping Hu, Shuling Wu, Ruyu Liu, Hongxiao Hao, Pan Zhu and Gang Yang and has published in prestigious journals such as Journal of Materials Chemistry, Frontiers in Immunology and Medicine.

In The Last Decade

Ge Shen

29 papers receiving 353 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Ge Shen 230 195 75 49 46 32 356
Stephan Moser 101 0.4× 89 0.5× 69 0.9× 44 0.9× 32 0.7× 25 265
Dina Elhammady 126 0.5× 114 0.6× 28 0.4× 44 0.9× 23 0.5× 24 222
Aslı Örmeci 172 0.7× 129 0.7× 75 1.0× 30 0.6× 21 0.5× 42 333
Mohamed‐Naguib Wifi 110 0.5× 106 0.5× 65 0.9× 16 0.3× 19 0.4× 15 246
Jessica Wen 278 1.2× 282 1.4× 46 0.6× 11 0.2× 54 1.2× 28 420
Xiajie Wen 113 0.5× 90 0.5× 115 1.5× 11 0.2× 38 0.8× 18 299
Eman Rewisha 174 0.8× 200 1.0× 18 0.2× 26 0.5× 11 0.2× 30 249
Zhili Niu 46 0.2× 42 0.2× 82 1.1× 57 1.2× 27 0.6× 11 217
Rekha Hans 60 0.3× 44 0.2× 31 0.4× 39 0.8× 20 0.4× 35 219
Sergio Scaccabarozzi 326 1.4× 334 1.7× 44 0.6× 24 0.5× 13 0.3× 10 419

Countries citing papers authored by Ge Shen

Since Specialization
Citations

This map shows the geographic impact of Ge Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ge Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ge Shen more than expected).

Fields of papers citing papers by Ge Shen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ge Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ge Shen. The network helps show where Ge Shen may publish in the future.

Co-authorship network of co-authors of Ge Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Ge Shen. A scholar is included among the top collaborators of Ge Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ge Shen. Ge Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Cao, Weihua, Lu Zhang, Xiaoyue Bi, et al.. (2022). Expression of Functional Molecule on Plasmacytoid Dendritic Cells Is Associated With HBsAg Loss in HBeAg-Positive Patients During PEG-IFN α-2a Treatment. Frontiers in Immunology. 13. 891424–891424. 5 indexed citations
3.
Li, Minghui, Fangfang Sun, Zhan Zeng, et al.. (2022). Dynamic Changes of Cytokine Profiles and Virological Markers Associated With HBsAg Loss During Peginterferon Alpha-2a Treatment in HBeAg-Positive Chronic Hepatitis B Patients. Frontiers in Immunology. 13. 892031–892031. 10 indexed citations
4.
Wu, Shuling, Wei Yi, Yuanjiao Gao, et al.. (2022). Immune Mechanisms Underlying Hepatitis B Surface Antigen Seroclearance in Chronic Hepatitis B Patients With Viral Coinfection. Frontiers in Immunology. 13. 893512–893512. 12 indexed citations
5.
Li, Minghui, Yuanjiao Gao, Yang Liu, et al.. (2022). Dynamic changes of cytokine profiles and virological markers during 48 weeks of entecavir treatment for HBeAg-positive chronic hepatitis B. Frontiers in Immunology. 13. 1024333–1024333. 4 indexed citations
6.
Lu, Qingqing, Zhenhua Zhu, Chaochao Tan, et al.. (2021). Changes of serum IL‐10, IL‐1β, IL‐6, MCP‐1, TNF‐α, IP‐10 and IL‐4 in COVID‐19 patients. International Journal of Clinical Practice. 75(9). e14462–e14462. 57 indexed citations
7.
Cao, Weihua, Minghui Li, Lu Zhang, et al.. (2021). The Characteristics of Natural Killer Cells in Chronic Hepatitis B Patients Who Received PEGylated‐Interferon versus Entecavir Therapy. BioMed Research International. 2021(1). 2178143–2178143. 8 indexed citations
8.
Pan, Calvin Q., Minghui Li, Wei Yi, et al.. (2021). Outcome of Chinese patients with hepatitis B at 96 weeks after functional cure with IFN versus combination regimens. Liver International. 41(7). 1498–1508. 23 indexed citations
9.
Hu, Yan, Ge Shen, Qiong Li, et al.. (2020). Roles of 2 SARS-CoV-2 antibody assays in the diagnosis of corona virus disease 2019. Laboratory Medicine. 35(12). 1294.
10.
Liu, Ruyu, Yanhui Chen, Jiang Guo, et al.. (2020). The reduction in CD8+PD-1+ T cells in liver histological tissue is related to Pegylated IFN-α therapy outcomes in chronic hepatitis B patients. BMC Infectious Diseases. 20(1). 590–590. 7 indexed citations
11.
12.
Liu, Ruyu, Jiang Guo, Yao Lu, et al.. (2019). Changes in APRI and FIB-4 in HBeAg-negative treatment-naive chronic hepatitis B patients with significant liver histological lesions receiving 5-year entecavir therapy. Clinical and Experimental Medicine. 19(3). 309–320. 14 indexed citations
13.
Cao, Weihua, Minghui Li, Calvin Q. Pan, et al.. (2018). Quantitation of Plasmacytoid Dendritic Cells in Chronic Hepatitis B Patients with HBeAg Positivity During PEG-IFN and Entecavir Therapy. Journal of Interferon & Cytokine Research. 38(5). 197–205. 13 indexed citations
14.
Li, Minghui, Lu Zhang, Dan Zhang, et al.. (2018). Plasmacytoid Dendritic Cell Function and Cytokine Network Profiles in Patients with Acute or Chronic Hepatitis B Virus Infection. Chinese Medical Journal. 131(1). 43–49. 11 indexed citations
15.
Li, Minghui, Yao Lu, Lu Zhang, et al.. (2018). Association of Cytokines with Alanine Aminotransferase, Hepatitis B Virus Surface Antigen and Hepatitis B Envelope Antigen Levels in Chronic Hepatitis B. Chinese Medical Journal. 131(15). 1813–1818. 12 indexed citations
16.
Li, Minghui, Dan Zhang, Lu Zhang, et al.. (2017). Ratios of T-helper 2 Cells to T-helper 1 Cells and Cytokine Levels in Patients with Hepatitis B. Chinese Medical Journal. 130(15). 1810–1815. 11 indexed citations
17.
Li, Minghui, Lu Zhang, Yao Lu, et al.. (2017). Kinetics of Hepatitis B Surface Antigen Level in Chronic Hepatitis B Patients who Achieved Hepatitis B Surface Antigen Loss during Pegylated Interferon Alpha-2a Treatment. Chinese Medical Journal. 130(5). 559–565. 17 indexed citations
18.
19.
Li, Minghui, Lu Zhang, Yao Lu, et al.. (2016). Hepatitis B surface antigen clearance in inactive hepatitis B surface antigen carriers treated with peginterferon alfa-2a. World Journal of Hepatology. 8(15). 637–637. 23 indexed citations
20.
Shen, Ge, Lu Zhang, Leiping Hu, et al.. (2013). [Study on the etiology of acute hepatitis hospitalized patients in Beijing Ditan Hospital from 2002 to 2011].. PubMed. 27(4). 266–9. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stephan Moser Breakdown of academic impact, for papers by Dina Elhammady Breakdown of academic impact, for papers by Aslı Örmeci Breakdown of academic impact, for papers by Mohamed‐Naguib Wifi Breakdown of academic impact, for papers by Jessica Wen Breakdown of academic impact, for papers by Xiajie Wen Breakdown of academic impact, for papers by Eman Rewisha Breakdown of academic impact, for papers by Zhili Niu Breakdown of academic impact, for papers by Rekha Hans Breakdown of academic impact, for papers by Sergio Scaccabarozzi
Rankless by CCL
2026